Repare Therapeutics Inc. (RPTX): Price and Financial Metrics
RPTX Price/Volume Stats
| Current price | $1.47 | 52-week high | $4.29 |
| Prev. close | $1.49 | 52-week low | $0.89 |
| Day low | $1.45 | Volume | 129,500 |
| Day high | $1.52 | Avg. volume | 297,272 |
| 50-day MA | $1.25 | Dividend yield | N/A |
| 200-day MA | $2.07 | Market Cap | 63.05M |
RPTX Stock Price Chart Interactive Chart >
Repare Therapeutics Inc. (RPTX) Company Bio
Repare Therapeutics, Inc. engages in the research, development, and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company was founded by Daniel Durocher, Agnel Sfeir and Frank Sicheri on September 6, 2016 and is headquartered in Saint-Laurent, Canada.
RPTX Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
RPTX Price Returns
| 1-mo | 8.09% |
| 3-mo | 24.05% |
| 6-mo | -52.27% |
| 1-year | -62.11% |
| 3-year | -89.76% |
| 5-year | N/A |
| YTD | 12.21% |
| 2024 | -82.05% |
| 2023 | -50.37% |
| 2022 | -30.25% |
| 2021 | -38.51% |
| 2020 | N/A |